Accessibility Menu
Akanda logo

Akanda(NASDAQ) AKAN

Market Cap$2.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-100%
5 YearN/A
1 Year-96%
1 Month-29%
$3.66
-2.14%
-0.08Today
Pre market$4.39+$0.73 (+19.95%)
Akanda last closing stock price
MetricPriceDate
Last closeUSD 3.672026-09-03
Akanda stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-13.24%USD 4.232026-08-27
1 month-28.88%USD 5.162026-08-04
3 month-76.52%USD 15.632026-06-05
Year to date-64.33%USD 10.292025-12-31
1 year-95.51%USD 81.682025-09-03
3 year-99.88%USD 2,944.692023-09-01
Since inception-100%USD 590,624.262022-03-15

Akanda Financials at a Glance

Market Cap

$2.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.09M

Net Income (TTM)

-$49.67M

EPS (TTM)

-$145.41

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$3.66

Volume

11,712,818

Open

$3.78

Previous Close

$3.67

Daily Range

$3.65 - $3.78

52-Week Range

$2.30 - $209.03

Estimated Earnings Date

Apr 29, 2026

AKAN News

GettyImages-1294843884

Why Akanda Stock Blasted Nearly 14% Higher Today

Eric VolkmanMar 21, 2022

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Akanda

Akanda Corp. is a cannabis-focused company engaged in the cultivation, production, and distribution of cannabis products for medical and wellness purposes. Operating primarily in the United Kingdom and Lesotho, Akanda aims to meet the growing demand for cannabis-derived items globally.

Products and Services
  • High-quality cannabis products for medical use
  • Wellness-focused cannabis-derived items
  • Global distribution network across multiple regions
Growth Outlook
  • Significant market potential in the expanding cannabis industry
  • Strategic operations in the UK and Lesotho enhance market reach
  • Focus on medical cannabis aligns with increasing global demand
Financial Highlights
  • Recent quarterly revenue of $258,075, showing potential for growth
  • Trailing twelve months (TTM) revenue of $1,000,000, indicating market presence
  • Cash and cash equivalents of $503,562 as of Q4 2025, supporting operations
Akanda Corp. operates in the rapidly evolving cannabis sector, which is witnessing increasing acceptance and demand for medical cannabis products. The company's strategic focus on cultivation and distribution positions it well to capitalize on this growth. Recent financial data indicates a revenue stream that, while modest, reflects the company's potential to expand its market presence. The operations in the UK and Lesotho provide a unique advantage, allowing Akanda to tap into diverse markets and consumer bases. With a commitment to quality and wellness, Akanda Corp. is poised to play a significant role in the future of the cannabis industry.
AI Generated • Aug 20, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

8

CEO

Katharyn M. Field, MBA

Website

www.akandacorp.com

Headquarters

Toronto, ON M5X 1G5, CA

AKAN Financials

Key Financial Metrics (TTM)

Gross Margin

-382.68%

Operating Margin

-2022.68%

Net Income Margin

-17658.53%

Return on Equity

1217.88%

Return on Capital

-144.39%

Return on Assets

-735.56%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

785.70K

Volume

11.71M

Avg. Volume

714.13K

Financials (TTM)

Gross Profit

-$779.22K

Operating Income

-$9.60M

EBITDA

-$7.88M

Operating Cash Flow

-$10.71M

Capital Expenditure

-$3.33M

Free Cash Flow

-$14.04M

Cash & ST Invst.

$503.56K

Total Debt

$14.24M

Akanda Performance Analysis

Akanda annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,619,6826223.0%
20232023-12-31USD 423,683-83.8%
20242024-12-31USD 0N/A
20252025-12-31USD 258,075N/A
Akanda sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-37.5%
Q42024-12-31-24.6%
Q22025-06-30-100.0%
Q42025-12-31N/A
Akanda annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -21,909.3838.4%
20232023-12-31USD -40,296.5483.9%
20242024-12-31USD -276.40-99.3%
20252025-12-31USD -669.96142.4%
Akanda sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30100.0%
Q42024-12-3186.1%
Q22025-06-3016.2%
Q42025-12-31-1488.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$258.08K

-66.2%

Gross Profit

-$903.74K

-9.7%

Gross Margin

-3.50%

N/A

Market Cap

$2.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$360.43K

N/A

Employees

8

N/A

Net Income

-$44.76M

-69.6%

EBITDA

-$3.38M

-73.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$503.56K

+436.4%

Total Debt

$14.24M

+256.0%

Accounts Receivable

$1.40M

+392.1%

Inventory

$0.00

-100.0%

Long Term Debt

$11.99M

+380.0%

Short Term Debt

$2.25M

+49.8%

Return on Assets

-7.36%

N/A

Return on Invested Capital

1370.08%

N/A

Free Cash Flow

-$7.59M

-1189.0%

Operating Cash Flow

-$6.35M

-978.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UPCUniverse Pharmaceuticals Inc.
$4.33-9.22%
GCTKGlucoTrack, Inc.
$3.32-5.95%
RDHLRedHill Biopharma Ltd.
$0.71-3.81%
SHPHShuttle Pharmaceuticals Holdings, Inc.
$3.48-0.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$106.74+0.00%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$51.60-0.00%
IBITiShares Bitcoin Trust
$46.35+0.06%

Questions About AKAN

What is the current price of Akanda?

Akanda is trading at $3.67 per share.

What is the 52-week range for Akanda?

Over the past 52 weeks, Akanda has traded between $2.30 and $209.03.

How much debt does Akanda have?

As of the most recent reporting period, Akanda reported total debt of $14.24M.

How much cash does Akanda have on hand?

Akanda reported $504.14K in cash and cash equivalents in its most recent financial results.

What is Akanda’s dividend yield?

Akanda does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services